Articoli correlati a Signal and Response Signal Transduction: Deadly Malignancy...

Signal and Response Signal Transduction: Deadly Malignancy and Blood Brain Barrier Studies - Rilegato

 
9781728386867: Signal and Response Signal Transduction: Deadly Malignancy and Blood Brain Barrier Studies
  • EditoreAuthorhouse
  • Data di pubblicazione2019
  • ISBN 10 1728386861
  • ISBN 13 9781728386867
  • RilegaturaCopertina rigida
  • LinguaInglese
  • Numero di pagine302

EUR 5,95 per la spedizione da Regno Unito a U.S.A.

Destinazione, tempi e costi

Altre edizioni note dello stesso titolo

9781728386294: Signal and Response Signal Transduction: Deadly Malignancy and Blood Brain Barrier Studies

Edizione in evidenza

ISBN 10:  1728386292 ISBN 13:  9781728386294
Casa editrice: Authorhouse, 2019
Brossura

Risultati della ricerca per Signal and Response Signal Transduction: Deadly Malignancy...

Foto dell'editore

Baidwan-Macfarland, Dr Amrit Rattan K
Editore: Authorhouse UK, 2019
ISBN 10: 1728386861 ISBN 13: 9781728386867
Nuovo Rilegato
Print on Demand

Da: PBShop.store UK, Fairford, GLOS, Regno Unito

Valutazione del venditore 4 su 5 stelle 4 stelle, Maggiori informazioni sulle valutazioni dei venditori

HRD. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo L1-9781728386867

Contatta il venditore

Compra nuovo

EUR 383,99
Convertire valuta
Spese di spedizione: EUR 5,95
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Foto dell'editore

Baidwan-Macfarland, Dr Amrit Rattan K
Editore: Authorhouse UK, 2019
ISBN 10: 1728386861 ISBN 13: 9781728386867
Nuovo Rilegato
Print on Demand

Da: PBShop.store US, Wood Dale, IL, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

HRD. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo L1-9781728386867

Contatta il venditore

Compra nuovo

EUR 404,02
Convertire valuta
Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Foto dell'editore

Baidwan-Macfarland, Dr Amrit Rattan K
Editore: Authorhouse UK, 2019
ISBN 10: 1728386861 ISBN 13: 9781728386867
Nuovo Rilegato

Da: Ria Christie Collections, Uxbridge, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. In. Codice articolo ria9781728386867_new

Contatta il venditore

Compra nuovo

EUR 390,49
Convertire valuta
Spese di spedizione: EUR 14,21
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Baidwan-Macfarland, Amrit Rattan K
Editore: AuthorHouse UK, 2019
ISBN 10: 1728386861 ISBN 13: 9781728386867
Nuovo Rilegato

Da: moluna, Greven, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. KlappentextrnrnThe ground-breaking scientific study of Amrit Rattan K Baidwan Macfarland (Amrit K Macfarland) asks why and how malignant cancers can be cured. This scientific status is visualised through novel ALL cells lines in vitro, in vivo, . Codice articolo 448285927

Contatta il venditore

Compra nuovo

EUR 413,33
Convertire valuta
Spese di spedizione: EUR 48,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Amrit Rattan K Baidwan-Macfarland
Editore: Authorhouse UK, 2019
ISBN 10: 1728386861 ISBN 13: 9781728386867
Nuovo Rilegato
Print on Demand

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Buch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The ground-breaking scientific study of Amrit Rattan K Baidwan Macfarland (Amrit K Macfarland) asks why and how malignant cancers can be cured. This scientific status is visualised through novel ALL cells lines in vitro, in vivo, and in developing natural human foetal tissues. The resistance status of malignancy to treatment is determined by an inextricable connection between P-gp expression in malignant cell membranes exposed to drugs, blood-brain barrier developmental cells in human foetal cells, and ALL blood cells undergoing chemotherapy. A new type of concept is introduced here as a human P-gp resistance amalgamation (P-gp-MDR) is conceived. Multidrug resistance is created due to cellular and barrier programs through the expression of a membrane drug efflux pump with an ability to create downstream signal transduction systems and which regulates its function and activity. This includes cellular and barrier capacities to generate unforeseen, innovative signalling pathways on multiple levels that can jeopardise treatment pathways at key stages in a fatal way. At present, these systems were unrecognised as potential elements for targeting the killing of deadly malignancies, both in primary and secondary forms. The fact that the blood-brain barrier is such a robust, intelligent entity, interfaced between blood and brain, indicates that it is the essential guardian for the survival of the brain, and thus all human biological systems depend on it. Its expression is seen in developing foetal brain tissues. However, it is also a stumbling block to the eradication of malignant cells. These findings of inducible P-gp expression in cancer cells and those that will constitute the blood-brain barrier creates intense tension both in the malignant systems as well as in the natural systems surrounding them, raising questions as to how to intervene to preserve the normal and retain its autonomy whilst destroying destructive actions, like hijackings by the malignant cells; the source of these abnormal responses remains to be answered. This book dynamically argues that P-gp MDR 1 and MDR 3 and the expressive Pg-p brain-blood functions are necessary to address for new chemotherapeutic challenges. It is important to study in general and specific, intelligent malignant, and natural systems that create multidrug resistance to treatment. The creativity and actions of P-gp and its polymorphisms are distinct in natural cells and malignant cells, and P-gp and its polymorphisms are involved in the creation of acute multidrug resistance, and they act as deadly programmed protectors of the biological environments of malignant cells and the cells exposed to drug treatments. As such the structure and function of P-gp together constitutes fatal ends for the host and its systems - based on studies of human cell lines, in vitro systems, in vivo foetal systems, in vivo blood cell systems - and exhibits non-cooperation of cells to multidrug treatments. In short, ALL is a multifaceted disease and displays abnormal activation of signalling pathways, which in turn activate drug-resistance pumps. The ability to target elements that activate the drug transporter P-gp will then be key to success to overcome cancers in this cutting edge field of nano-micro-molecular genetics. AUTHORHOUSE - ACADEMIC PRESS. Codice articolo 9781728386867

Contatta il venditore

Compra nuovo

EUR 609,16
Convertire valuta
Spese di spedizione: EUR 31,21
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello